Connect your AI

Zymeworks ZYME Total Current Assets

Total Current Assets at other companies

PfizerPFE

$42.82B-6.6%

AmgenAMGN

$31.48B+16.9%

AnaptysBio, Inc.ANAB

$316.11M-12.9%

Viridian Therapeutics, Inc.VRDN

$784.74M+19.4%

AbCellera Biologics Inc.ABCL

$664.6M-13.1%

Stoke Therapeutics, Inc.STOK

$366.68M-2.4%

Other financials

Income statement

Revenue$2.4M-91.1%

Operating income-$47.1M-84.0%

Net income-$44.2M-95.1%

EPS (diluted)-$0.59-96.7%

Balance sheet

Cash & equivalents$244.3M+221%

Total debt$17.0M-7.7%

Total equity$163.6M-49.7%

Total assets$478.2M+12.4%

Cash flow

Operating cash flow-$45.7M-1,242%

CapEx$216.0K+1,250%

Free cash flow-$45.9M-1,242%

Valuation

Market cap$1.76B+125%

Enterprise value$1.53B+112%

P/S21.6×+13.2×

Profitability

Operating margin-140.4%+7.3pp

Net margin-126.3%+5.0pp

FCF margin-94.8%+15.5pp

Returns & leverage

Return on equity-42%+29.2pp

Debt / equity0.1×0.0×

Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Zymeworks's total current assets?: Zymeworks (ZYME) reported total current assets of $385.68M in Q1 2026.
How has Zymeworks's total current assets changed year-over-year?: Zymeworks's total current assets increased by 25.8% year-over-year, from $306.47M to $385.68M.
What is the long-term trend for Zymeworks's total current assets?: Over 4 years (2021 to 2025), Zymeworks's total current assets has grown at a -3.6% compound annual growth rate (CAGR), from $288.22M to $248.77M.
What does total current assets mean?: The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.